Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: United States Clear all

118 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20042
20055
20063
20087
20092
20105
20116
20124
20134
20145
20155
20165
20177
20185
20195
20204
20217
20228
20236
20244
20255
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70
Terminated21
Active, not recruiting12
Recruiting11
Withdrawn3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)9
MedImmune LLC5
Amgen4
Bristol-Myers Squibb4
UCB Pharma4
Genentech, Inc.3
GlaxoSmithKline3
NYU Langone Health3
Northwell Health3
Novartis Pharmaceuticals3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic118
Autoimmune Diseases12
Lupus Nephritis10
Arthritis, Rheumatoid7
Lupus Erythematosus, Cutaneous5
Connective Tissue Diseases4
Immune System Diseases4
Lupus Erythematosus, Discoid3
Arthritis, Juvenile2
Cognitive Dysfunction2

Trials

Showing 1 to 25 of 118. Each trial links to its page on Pharma Observatory.

18 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.